POG 9406

(POG-ALINC-16-/HR)

Phase III Randomized Study of High Versus Standard Dose Methotrexate and High Dose Cytarabine and Asparaginase Rescue Versus Standard Dose Cytarabine and Teniposide During Intensive Continuation and Consolidation in Children with High Risk Acute Lymphocytic Leukemia: An ALinC #16 Study.

This trial on the cancer.gov site.

Treatment for high-risk ALL, defined as

Protocol initiated: (?), 540 patients over approximately 3.8 years

Study Chair: Joanne Kurtzberg 919-684-8963

Specific Aims:

Also:

Protocol outline:

4 arms of treatment:

POG 9406


Notes:

Compared with the current CCG higher risk protocol (CCG 1961), POG 9406 utilizes the following not in the CCG trial:

Back to ALL Trials page

Ped-Onc Resource Center Home


General Disclaimer : These pages are intended for informational purposes only and are not intended to render medical advice. The information provided on Ped Onc Resource Center should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you suspect your child has a health problem, you should consult your health care provider.

Last Updated 4/06

email the editor